VYNE Therapeutics Inc.

Contributing Author

Recent Articles by VYNE Therapeutics Inc.

Nov-06	VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update VYNE GlobeNewswire
Aug-14	VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update VYNE GlobeNewswire
Jul-30	VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo VYNE GlobeNewswire
Jul-02	VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202 VYNE GlobeNewswire
May-08	VYNE Therapeutics Reports 2025 First Quarter Financial Results and Provides Business Update VYNE GlobeNewswire